XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.4
Shareholders' Equity (Tables)
9 Months Ended
Jan. 28, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Stock Buyback Activity Under Share Buyback Program

The following table summarizes the Company’s stock buyback activity under this share buyback program:

 

 

Three Months Ended

 

 

Nine Months Ended

 

(in millions, except share and per share data)

 

January 28, 2023

 

 

January 29, 2022

 

 

January 28, 2023

 

 

January 29, 2022

 

Shares purchased

 

 

179,700

 

 

 

460,161

 

 

 

1,005,514

 

 

 

1,425,190

 

Average price per share

 

$

44.54

 

 

$

46.39

 

 

$

39.34

 

 

$

44.73

 

Total cost

 

$

8.0

 

 

$

21.3

 

 

$

39.6

 

 

63.7

 

Summary of Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax A summary of changes in AOCI, net of tax is shown below:

 

 

Three Months Ended January 28, 2023

 

 

Nine Months Ended January 28, 2023

 

(in millions)

 

Currency translation adjustments

 

 

Derivative instruments

 

 

Total

 

 

Currency translation adjustments

 

 

Derivative instruments

 

 

Total

 

Balance at beginning of period

 

$

(61.1

)

 

$

6.8

 

 

$

(54.3

)

 

$

(30.5

)

 

$

3.7

 

 

$

(26.8

)

  Other comprehensive income (loss)

 

 

37.7

 

 

 

(5.8

)

 

 

31.9

 

 

 

6.9

 

 

 

(1.7

)

 

 

5.2

 

  Tax (expense) benefit

 

 

(0.6

)

 

 

1.4

 

 

 

0.8

 

 

 

(0.4

)

 

 

0.4

 

 

 

 

Net other comprehensive income (loss)

 

 

37.1

 

 

 

(4.4

)

 

 

32.7

 

 

 

6.5

 

 

 

(1.3

)

 

 

5.2

 

Balance at the end of period

 

$

(24.0

)

 

$

2.4

 

 

$

(21.6

)

 

$

(24.0

)

 

$

2.4

 

 

$

(21.6

)

 

 

 

Three Months Ended January 29, 2022

 

 

Nine Months Ended January 29, 2022

 

(in millions)

 

Currency translation adjustments

 

 

Derivative instruments

 

 

Total

 

 

Currency translation adjustments

 

 

Derivative instruments

 

 

Total

 

Balance at beginning of period

 

$

0.8

 

 

$

(2.8

)

 

$

(2.0

)

 

$

11.5

 

 

$

(5.4

)

 

$

6.1

 

  Other comprehensive income (loss)

 

 

(11.1

)

 

 

3.2

 

 

 

(7.9

)

 

 

(21.9

)

 

 

6.5

 

 

 

(15.4

)

  Tax (expense) benefit

 

 

0.1

 

 

 

(0.8

)

 

 

(0.7

)

 

 

0.2

 

 

 

(1.5

)

 

 

(1.3

)

Net other comprehensive income (loss)

 

 

(11.0

)

 

 

2.4

 

 

 

(8.6

)

 

 

(21.7

)

 

 

5.0

 

 

 

(16.7

)

Balance at the end of period

 

$

(10.2

)

 

$

(0.4

)

 

$

(10.6

)

 

$

(10.2

)

 

$

(0.4

)

 

$

(10.6

)

 

Summary of RSA and RSU Activity

The following table summarizes RSA activity:

 

 

Restricted
stock
awards

 

 

Weighted
average grant
date fair value

 

Non-vested at April 30, 2022

 

 

928,412

 

 

$

28.50

 

Awarded

 

 

21,262

 

 

$

38.41

 

Vested

 

 

 

 

$

 

Forfeited

 

 

 

 

$

 

Non-vested at January 28, 2023

 

 

949,674

 

 

$

28.72

 

 

The following table summarizes RSU activity:

 

 

Restricted
stock
units

 

 

Weighted
average grant
date fair value

 

Non-vested at April 30, 2022

 

 

936,391

 

 

$

29.16

 

Awarded

 

 

74,508

 

 

$

39.21

 

Vested

 

 

 

 

$

 

Forfeited

 

 

(734

)

 

$

48.41

 

Non-vested at January 28, 2023

 

 

1,010,165

 

 

$

29.89

 

Summary of combined stock option activity and related information for stock options granted

The following table summarizes stock option activity:

 

 

Stock
options

 

 

Weighted average exercise price

 

 

Weighted-
average life
(years)

 

 

Aggregate
intrinsic value
(in millions)

 

Outstanding and exercisable at April 30, 2022

 

 

60,000

 

 

$

37.01

 

 

 

2.2

 

 

$

0.5

 

Exercised

 

 

(40,000

)

 

$

37.01

 

 

 

 

 

 

 

Forfeited

 

 

 

 

$

 

 

 

 

 

 

 

Outstanding and exercisable at January 28, 2023

 

 

20,000

 

 

$

37.01

 

 

 

1.4

 

 

$

0.2

 

Summary of Stock-based Compensation Expense Related to Equity Awards The table below summarizes the stock-based compensation expense related to the equity awards:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

(in millions)

 

January 28, 2023

 

 

January 29, 2022

 

 

January 28, 2023

 

 

January 29, 2022

 

RSUs

 

$

2.7

 

 

$

2.6

 

 

$

7.8

 

 

$

7.7

 

Deferred director awards

 

 

 

 

 

 

 

 

1.0

 

 

 

0.8

 

Director awards

 

 

 

 

 

 

 

 

0.6

 

 

 

0.7

 

Total stock-based compensation expense

 

$

2.7

 

 

$

2.6

 

 

$

9.4

 

 

$

9.2